Fair 71°
Tag:

Dr. Scott Gottlieb

News
COVID-19: Subvariant XBB Accounts For 70% Of New England Cases, Sparking Concerns Of New Wave COVID-19: Subvariant XBB Accounts For 70% Of New England Cases, Sparking Concerns Of New Wave
Covid-19: Subvariant XBB Accounts For 70% Of New England Cases, Sparking Concerns Of New Wave An Omicron strain called XBB.1.5 which now accounts for the majority of COVID-19 cases from the New York tristate area through New England has the potential to trigger a new wave of infections, a top expert is now saying. The XBB.1.5 variant makes up 40.5 percent of cases in the United States, and 70 percent of cases in the New York tristate area through New England, according to the Centers for Disease Control and Prevention (CDC). "I would expect a wave of infection with this new variant," Dr. Scott Gottlieb, former commissioner of the Food and Drug Administration (FDA), told MS…

SHARE

by Joe Lombardi
News
COVID-19: US Sees Record 1.35M Cases In A Day, But Expert Says That Doesn't Tell Whole Story COVID-19: US Sees Record 1.35M Cases In A Day, But Expert Says That Doesn't Tell Whole Story
Covid-19: US Sees Record 1.35M Cases In A Day, But Expert Says That Doesn't Tell Whole Story Fueled by the highly contagious Omicron variant, the United States reported a record-breaking 1.35 million COVID-19 infections in a day on Monday, Jan. 10.  But that may not even be close to the actual number of cases. "We're probably only diagnosing somewhere between one in five and one in 10 actual infections," Former FDA Commissioner Dr. Scott Gottlieb said Sunday, Jan. 9 on CBS-TV. Gottlieb added that there are "probably a lot of people walking around with asymptomatic infection who don't know it, but are spreading it." That scenario could cause staffing issues for hospitals, and…

SHARE

by Joe Lombardi
News
COVID-19: Wave Of Omicron Cases In US May Be At Turning Point, Virus Expert Says COVID-19: Wave Of Omicron Cases In US May Be At Turning Point, Virus Expert Says
Covid-19: Wave Of Omicron Cases In US May Be At Turning Point, Virus Expert Says The wave of COVID-19 cases in the United States triggered by the highly contagious Omicron variant may be at a turning point, an infectious disease expert says. Former FDA commissioner Dr. Scott Gottlieb says parts of the nation may be about to pass the peak phase of the outbreak, while other regions will likely soon be hit hard. "f you look what's happening across the East Coast right now in New York City, Washington, DC, Maryland, probably Florida as well have already peaked, maybe Delaware and Rhode Island," Gottlieb said Sunday, Jan. 9 on CBS-TV's "Face the Nation." "You start to see t…

SHARE

by Joe Lombardi
Lifestyle
COVID-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says COVID-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says
Covid-19: True Delta Wave Has Not Yet Hit Northeast, Former FDA Commissioner Says The "true delta wave" has not hit the Northeast yet, and it will arrive sometime after Labor Day weekend, former United States Food and Drug Administration Commissioner Dr. Scott Gottlieb said. Gottlieb said in an interview with CNBC on Friday, Sept. 3, that he thinks the jump in delta variant cases in the Northeast that has since decreased was a warning for another spike in cases that will hit the region. He predicted that gatherings during Labor Day weekend and children returning to school will lead to cases increasing once again. Gottlieb recommended that schools increase the frequency …

SHARE

by Nicole Valinote
News
COVID-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11 COVID-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11
Covid-19: Here's When Vaccine Rollout May Start For Kids Ages 5 To 11 The Pfizer COVID-19 vaccine could be available to children ages 5 and older late in the fall or early this winter, according to a company board member. Former Food and Drug Administration (FDA) Commissioner Dr. Scott Gottlieb told CNBC that he believes the company's COVID vaccine will be approved for emergency use for children ages 5 to 11 sometime this fall or winter. Gottlieb told the news outlet that the application will likely be submitted to the FDA in October.  He said the FDA will likely take four-to-six weeks to review the application, so the emergency use authorization c…

SHARE

by Nicole Valinote